Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma

Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma

Objectives: Circulating cell-free DNA (cfDNA) is a potential biomarker for tumor diagnosis. Hepatocyte damage is a characteristic component of the pathobiology of hepatocellular carcinoma (HCC), which would be expected to result in substantial leakage of cfDNA into the circulation. However, the diag...

Full description

Bibliographic Details
Main Authors:	Linlin Yan, Yanhui Chen, Jiyuan Zhou, Hong Zhao, Henghui Zhang, Guiqiang Wang
Format:	Article
Language:	English
Published:	Elsevier 2018-02-01
Series:	International Journal of Infectious Diseases
Subjects:	Circulating cell-free DNA Hepatocellular carcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971217303144

Similar Items

Targeted Next-Generation Sequencing Combined With Circulating-Free DNA Deciphers Spatial Heterogeneity of Resected Multifocal Hepatocellular Carcinoma
by: Jianzhen Lin, et al.
Published: (2021-06-01)

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
by: Yasutoshi Fujii, et al.
Published: (2021-06-01)

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
by: Charlotte K. Y. Ng, et al.
Published: (2018-03-01)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Jie Li, et al.
Published: (2018-09-01)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
by: Yuyuan Zhang, et al.
Published: (2021-09-01)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
by: Zhouhong Ge, et al.
Published: (2021-07-01)

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
by: Marianna Alunni-Fabbroni, et al.
Published: (2019-10-01)

Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer
by: Dauksa, A., et al.
Published: (2022)

Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma
by: Xiong Y, et al.
Published: (2019-06-01)

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes
by: Silvia Mezzalira, et al.
Published: (2019-11-01)

Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis
by: Ziying Zhang, et al.
Published: (2020-02-01)

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
by: Francesca Pezzuto, et al.
Published: (2018-03-01)

Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
by: Chung Ryul Oh, et al.
Published: (2019-04-01)

Relationship between hepatocellular carcinoma circulating tumor cells and tumor volume
by: Rahmi Oklu, et al.
Published: (2018-07-01)

Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma
by: Stine Karlsen Oversoe, et al.
Published: (2021-04-01)

Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma
by: Ye X, et al.
Published: (2018-11-01)

Diagnostic and Prognostic Value of Circulating Cell‐Free DNA for Cholangiocarcinoma
by: Preawwalee Wintachai, et al.
Published: (2021-05-01)

Characterization of fragment sizes, copy number aberrations and 4‐mer end motifs in cell‐free DNA of hepatocellular carcinoma for enhanced liquid biopsy‐based cancer detection
by: Chao Jin, et al.
Published: (2021-09-01)

Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma
by: Chih-Cheng Hsieh, et al.
Published: (2016-12-01)

Using cell-free DNA for HCC surveillance and prognosisKey points
by: Nguyen H. Tran, et al.
Published: (2021-08-01)

Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
by: Zhang Q, et al.
Published: (2021-03-01)

Detection of <i>CTNNB1</i> Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients
by: Selena Y. Lin, et al.
Published: (2021-08-01)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
by: Panagiota Maravelia, et al.
Published: (2021-08-01)

Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme
by: Hua Ying, et al.
Published: (2021-01-01)

Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
by: Jing-jing Yu, et al.
Published: (2018-08-01)

Diagnostic value of combined determination of DNA ploidy level and miRNA-21 expression in ascites cells for hepatocellular carcinoma
by: XIAO Zuohan
Published: (2015-01-01)

Potential clinical application of free-circulating DNA from blood in renal cancer
by: E. I. Yakubovich, et al.
Published: (2020-11-01)

Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
by: Pei Meng, et al.
Published: (2019-08-01)

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
by: Wei Zhang, et al.
Published: (2017-02-01)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
by: Chen Q, et al.
Published: (2019-12-01)

Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand
by: Pattapon Kunadirek, et al.
Published: (2021-05-01)

Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis
by: Dandan Yu, et al.
Published: (2019-03-01)

Current status of ctDNA in precision oncology for hepatocellular carcinoma
by: Yan Li, et al.
Published: (2021-04-01)

Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
by: Wang X, et al.
Published: (2020-10-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01)

Mixed hepatocellular carcinoma-neuroendocrine carcinoma—A diagnostic and therapeutic challenge
by: Nusrat Jahan, et al.
Published: (2020-12-01)

Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis
by: Jun-Li Fan, et al.
Published: (2015-09-01)

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies
by: Kabir Mody, et al.
Published: (2018-06-01)

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
by: Li-Yue Sun, et al.
Published: (2021-02-01)